| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 195.00 +1.60% on 04/04/25 |
Period Open: 217.21
| 228.45 -13.28% on 03/28/25 | -19.10 (-8.79%) since 03/04/25 |
| 3-Month | 195.00 +1.60% on 04/04/25 |
Period Open: 203.86
| 228.45 -13.28% on 03/28/25 | -5.75 (-2.82%) since 01/03/25 |
| 52-Week | 139.50 +42.01% on 07/09/24 |
Period Open: 197.75
| 242.74 -18.39% on 12/11/24 | +0.36 (+0.18%) since 04/04/24 |
/Paycom%20Software%20Inc%20logo%20on%20laptop-by%20monticello%20via%20Shutterstock.jpg)
Although Paycom Software has recently outperformed the Dow Jones Industrial Average, Wall Street analysts remain wary of its future prospects.
Investors in Paycom Software, Inc. PAYC need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 16, 2026 $350.00 Put had some of the highest implied...
With the stock market in turmoil as economic uncertainty ramps up, long-term investors have an opportunity to pick up high-quality stocks at attractive prices. While there's no telling how much further...
HR Software Stocks Q4 Recap: Benchmarking Paychex (NASDAQ:PAYX)
The S&P 500 Index ($SPX ) (SPY ) Monday closed down -2.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -2.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -3.81%. March E-mini...
The S&P 500 Index ($SPX ) (SPY ) today is down -1.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -3.18%. March E-mini S&P futures...
The S&P 500 Index ($SPX ) (SPY ) today is down -1.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.65%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.19%. March E-mini S&P futures...
2 Reasons to Like PAYC and 1 to Stay Skeptical
Three technology names are breaking out to within 90% of their 52-week highs, and factors suggest more upside is ahead. Wall Street analysts see upside
Tesla and Nissan arrangement speculated, Block disappoints on earnings, gold closes in on $3,000, and more...
/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and ProFound™ Therapeutics, a company pioneering the discovery of a vastly expanded...
/PRNewswire/ -- Flagship Pioneering today announced it has been named to FORTUNE's 2023 "Change the World" list, an annual global ranking of companies that...
/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today the appointment of Amanda Kay as Senior Partner and Chief Business...
/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today that pharma and healthcare leader David Khougazian is joining as...
/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and Ampersand Biomedicines, a company programming smarter medicines that act...
Good news drove shares of these stocks through the roof last week, but investors should be more concerned about their paths forward.
The company announced details of research on two of its pre-clinical therapies.
Cellarity , a life sciences company founded by Flagship Pioneering to transform the way medicines are discovered, announced today the appointments of John Leaman, M.D., M.B.A., as Chief Financial Officer...
Flagship Pioneering, the bioplatform innovation company, today unveiled Ampersand Biomedicines, a company creating programmable medicines that are safer, more tolerable, and effective by acting at the...
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a multi-program agreement with Pioneering Medicines, a strategic initiative of Flagship Pioneering, that gives Pioneering Medicines...
/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and ProFound™ Therapeutics, a company pioneering the discovery of a vastly expanded...
/PRNewswire/ -- Flagship Pioneering today announced it has been named to FORTUNE's 2023 "Change the World" list, an annual global ranking of companies that...
/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today the appointment of Amanda Kay as Senior Partner and Chief Business...
/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today that pharma and healthcare leader David Khougazian is joining as...
/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and Ampersand Biomedicines, a company programming smarter medicines that act...
Good news drove shares of these stocks through the roof last week, but investors should be more concerned about their paths forward.
The company announced details of research on two of its pre-clinical therapies.
Cellarity , a life sciences company founded by Flagship Pioneering to transform the way medicines are discovered, announced today the appointments of John Leaman, M.D., M.B.A., as Chief Financial Officer...
Flagship Pioneering, the bioplatform innovation company, today unveiled Ampersand Biomedicines, a company creating programmable medicines that are safer, more tolerable, and effective by acting at the...
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a multi-program agreement with Pioneering Medicines, a strategic initiative of Flagship Pioneering, that gives Pioneering Medicines...
| Symbol | %Holdings | 3M %Chg |
|---|---|---|
| PAYC | -2.82% | |
| Paycom Software Inc | ||
| RISN | 2.85% | -8.10% |
| Inspire Tactical Balanced ESG ETF | ||
| RDVY | 1.68% | -11.63% |
| Rising Dividend Achievers ETF FT | ||
| RDVI | 1.68% | -12.60% |
| FT Rising Dividend ETF | ||
| CLDL | 1.6% | -36.35% |
| Cloud Computing Bull 2X ETF Direxion | ||
| FXL | 1.55% | -23.03% |
| Technology Alphadex ETF FT | ||
| 3rd Resistance Point | 220.58 |
| 2nd Resistance Point | 214.84 |
| 1st Resistance Point | 206.47 |
| Last Price | 198.11 |
| 1st Support Level | 192.37 |
| 2nd Support Level | 186.63 |
| 3rd Support Level | 178.27 |
| 52-Week High | 242.74 |
| Fibonacci 61.8% | 203.30 |
| Last Price | 198.11 |
| Fibonacci 50% | 191.12 |
| Fibonacci 38.2% | 178.94 |
| 52-Week Low | 139.50 |
